Last updated: September 27, 2024
Sponsor: Guangzhou Women and Children's Medical Center
Overall Status: Completed
Phase
N/A
Condition
Holoprosencephaly
Treatment
N/AClinical Study ID
NCT03651687
2016111865-2
81673181
Ages < 24 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Newborns born after 24+0 weeks of gestation
Newborns delivered at the study hospitals
Exclusion
Exclusion Criteria:
With major congenital abnormalities
Multiple births
Study Design
Total Participants: 47369
Study Start date:
February 10, 2017
Estimated Completion Date:
September 27, 2024
Study Description
Connect with a study center
Guangzhou Women and Children's Medical Center, China
Guangzhou,
ChinaSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.